Efforts to take on Cigna’s and CVS’s pharmacy benefit managers won’t hurt as much as Wall Street expects.
Source link
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…
Natco Pharma’s consolidated net profit declined 37 per cent to ₹132 crore in the third…
The Securities and Exchange Board of India (Sebi) on Wednesday floated a consultation paper, proposing…
In a major relief to research analysts, the Securities and Exchange Board of India (SEBI)…
Upcoming IPO: BD Security Limited (BDS), a security services provider and Telecom O&M has received…
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories…